GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » Current Accrued Expense
中文

Biosyntech (Biosyntech) Current Accrued Expense : $1.38 Mil (As of Dec. 2009)


View and export this data going back to 2000. Start your Free Trial

What is Biosyntech Current Accrued Expense?

Biosyntech's Current Accrued Expense for the quarter that ended in Dec. 2009 was $1.38 Mil.

Biosyntech's quarterly Current Accrued Expense increased from Jun. 2009 ($0.75 Mil) to Sep. 2009 ($2.23 Mil) but then declined from Sep. 2009 ($2.23 Mil) to Dec. 2009 ($1.38 Mil).

Biosyntech's annual Current Accrued Expense increased from Mar. 2007 ($0.64 Mil) to Mar. 2008 ($0.70 Mil) and increased from Mar. 2008 ($0.70 Mil) to Mar. 2009 ($0.88 Mil).


Biosyntech Current Accrued Expense Historical Data

The historical data trend for Biosyntech's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech Current Accrued Expense Chart

Biosyntech Annual Data
Trend Mar00 Mar01 Mar02 Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.64 0.70 0.88

Biosyntech Quarterly Data
Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.88 0.75 2.23 1.38

Biosyntech Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Biosyntech Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Biosyntech's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosyntech (Biosyntech) Business Description

Traded in Other Exchanges
N/A
Address
475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3
Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines